Answers are grounded in this paper and cite their sources.
Analysis shows disparities in access to anticancer medicines in seven European countries, suggesting urgent reforms for equitable healthcare.
We recommend minimizing disparities between CUPs and NPBs across Europe to ensure equitable access for patients with high unmet medical needs. Reducing these differences is essential to protect patients from feeling compelled to travel abroad or bear the financial burden of obtaining medicines that are not authorized in their home country.
No takes yet. Share an insight, caveat, or question.
Rosenberg et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: